Birchview Capital’s Halozyme HALO Stock Holding History

Birchview Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.6M	Buy	33,251 +23,151	+229%	+$1.58M	1.22%	18
2026 Q1	$653K	Hold	10,100	–	–	0.37%	49
2025 Q4	$680K	Hold	10,100	–	–	0.4%	48
2025 Q3	$741K	Buy	10,100 +100	+1%	+$6.64K	0.56%	42
2025 Q2	$520K	Hold	10,000	–	–	0.52%	43
2025 Q1	$638K	Hold	10,000	–	–	0.55%	29
2024 Q4	$478K	Hold	10,000	–	–	0.39%	34
2024 Q3	$572K	Hold	10,000	–	–	0.5%	27
2024 Q2	$524K	Hold	10,000	–	–	0.48%	32
2024 Q1	$407K	Hold	10,000	–	–	0.33%	40
2023 Q4	$370K	Hold	10,000	–	–	0.29%	39
2023 Q3	$382K	Hold	10,000	–	–	0.32%	36
2023 Q2	$361K	Hold	10,000	–	–	0.27%	41
2023 Q1	$382K	Hold	10,000	–	–	0.3%	36
2022 Q4	$569K	Buy	+10,000	New	+$512K	0.4%	30

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Birchview Capital's HALO Position: Q2 2026 in Review

Birchview Capital increased its Halozyme (HALO) stake by 229% in Q2 2026, buying an estimated $1.58M and bringing the position to 33,251 shares worth $2.6M. The position accounts for 1.22% of the portfolio, ranked #18.

Birchview Capital first reported a position in HALO in Q4 2022 and has held it in 15 quarters since. 670 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Birchview Capital held 33,251 shares of Halozyme worth $2.6M as of Q2 2026.
Birchview Capital bought 23,151 Halozyme shares in Q2 2026, an estimated $1.58M.
Halozyme made up 1.22% of Birchview Capital's portfolio in Q2 2026, its #18 holding.
Birchview Capital first reported a position in Halozyme in Q4 2022 and has held it in 15 quarters since.
670 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.